ultomiris
Generic: ravulizumab-cwvz·Code: ALXN1210
ultomiris: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| ALEXION PHARMACEUTICALS, INC. (ALXN) | Phase 4 |
Get deeper analysis on ultomiris
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis